Home  >  Companies  >  Alloy Therapeutics
Alloy Therapeutics
Drug discovery platform and services for antibody, TCR mimic, and oligonucleotide therapeutics

Valuation

$1.00B

2026

Funding

$136.24M

2022

Details
Headquarters
Boston, United States
CEO
Errik Anderson
Website
Milestones
FOUNDING YEAR
2017

Filings

Company documents and regulatory filings for Alloy Therapeutics.

Name Type Filed At Actions
Form D — 0001851943-26-000001
Form D
Apr 15, 2026
View PDF
Form D — 0001851943-22-000001
Form D
Oct 03, 2022
View PDF
Form D — 0001851943-21-000001
Form D
Apr 02, 2021
View PDF
Details
Headquarters
Boston, United States
CEO
Errik Anderson
Website
Milestones
FOUNDING YEAR
2017